Inhibition of relapsing experimental autoimmune encephalomyelitis in SJL mice by feeding the immunodominant PLP139-151 peptide

Journal of Neuroscience Research

Volumn 45, Issue 4, 1996, Pages 410-423

  Karpus, William J ^a   Kennedy, K J ^a   Smith, W S ^a   Miller, S D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

anergy; central nervous system; oral tolerance; proteolipid protein; T helper 1; T helper 2

Indexed keywords

EPITOPE; PLP 139151; PROTEOLIPID PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CLONAL ANERGY; FEEDING; GENE DELETION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RELAPSE;

ADMINISTRATION, ORAL; ANIMALS; ANTIGEN PRESENTATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; IMMUNE TOLERANCE; IMMUNIZATION; IMMUNODOMINANT EPITOPES; INTERLEUKIN-4; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MYELIN PROTEINS; MYELIN PROTEOLIPID PROTEIN; PEPTIDE FRAGMENTS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0029741439     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19960815)45:4<410::AID-JNR10>3.0.CO;2-4     Document Type: Article

References (74)

1. Al-Sabbagh A, Miller A, Santos LMB, Weiner HL (1994): Antigen-driven tissue-specific suppression following oral tolerance: orally administered myelin basic protein suppresses proteolipid protein-induced experimental autoimmune encephalomyelitis in the SJL mouse. Eur J Immunol 24:2104-2109.
2. Arnason BG (1983): Relevance of experimental allergic encephalomyelitis to multiple sclerosis. Neurol Clin 1:765-782.
3. Asherson GL, Zembala M, Perera MACC, Mayhew B, Thomas WR (1977): Production of immunity and unresponsiveness in the mouse by feeding contact sensitizing agents and the role of suppressor cells in the Peyer's patches, mesenteric lymph nodes and other lymphoid tissues. Cell Immunol 33:145-155.
4. Bitar DM, Whitacre CC (1988): Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. Cell Immunol 112:364-370.
5. Braley-Mullen H, Tompson JG, Sharp GC, Kyriakos M (1980): Suppression of experimental autoimmune thyroiditis in guinea pigs by pretreatment with thyroglobulin-coupled spleen cells. Cell Immunol 51:408-413.
6. Brocke S, Gijbels K, Allegretta M, Feber I, Piercy C, Blankenstein T, Martin R, Utz U, Karin N, Mitchell D, VeromaaT, Waisman A, Gaur A, Conlon P, Ling N, Fairchild PJ, Wraith DC, O'Garra A, Fathman CG, Steinman L (1996): Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 379:343-346.
7. Burstein HJ, Shea CM, Abbas AK (1992): Aqueous antigens induce in vivo tolerance selectivity in IL-2-producing and IFN-γ-producing (Th1) cells. J Immunol 148:3687-3691.
8. Clatch RJ, Miller SD, Metzner R, Dal Canto MC, Lipton HL (1990): Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV). Virology 176:244-254.
9. 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis. Lab Invest 63:162-170.
10. Domen PL, Muckerheide A, Michael JG (1987): Cationization of protein antigens. III. Abrogation of oral tolerance. J Immunol 139:3195-3198.
11. Dua HS, Gregerson DS, Donoso LA (1992): Inhibition of experimental autoimmune uveitis by retinal photoreceptor antigens coupled to spleen cells. Cell Immunol 139:292-305.
12. Elson CO, Balding W (1984): Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. J Immunol 133:2892-2897.
13. Enomoto A, Konishi M, Hachimura S, Kaminogawa S (1993): Milk whey protein fed as a constituent of the diet induced both oral tolerance and a systemic humoral response, while heat-denatured whey protein induced only oral tolerance. Clin Immunol Immunopathol 66:136-142.
14. Faria AM, Garcia G, Rios MJ, Michalaros CL, Vaz NM (1993): Decrease in susceptibility to oral tolerance induction and occurrence of oral immunization to ovalbumin in 20-38-week-old mice: the effect of interval between oral exposures and rate of antigen intake in the oral immunization. Immunology 78:147-151.
15. Friedman A, Weiner HL (1994): Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci USA 91:6688-6692.
16. Garside P, Steel M, Worthey EA, Satoskar A, Alexander J, Bluethmann H, Liew FY, Mowat AM (1995): T helper 2 cells are subject to high dose oral tolerance and are not essential for its induction. J Immunol 154:5649-5655.
17. Gilbert KM, Hoang KD, Weigle WO (1990): Th1 and Th2 clones differ in their response to a tolerogenic signal. J Immunol 144: 2063-2071.
18. Gonatas NK, Greene MI, Waksman BH (1986): Genetic and molecular aspects of demyelination. Immunol Today 7:121-126.
19. Greer JM, Kuchroo VK, Sobel RA, Lees MB (1992): Identification and characterization of a second encephalitogenic determinant of myelin proteolipid protein (residues 178-191) for SJL mice. J Immunol 149:783-788.
20. Greer JM, Sobel RA, Sette A, Southwood S, Lees MB, Kuchroo VK (1996): Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein. J Immunol 156:371-379.
21. Hajishengallis G, Hollingshead SK, Koga T, Russell MW (1995): Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits. J Immunol 154: 4322-4332.
22. Hanson DG, Miller SD (1982): Inhibition of specific immune responses by feeding protein antigens. V. Induction of the tolerant state in the absence of specific suppressor cells. J Immunol 128:2378-2381.
23. Hickey WF, Gonatas NK, Kimura H, Wilson DB (1983): Identification and quantitation of T lymphocyte subsets found in the spinal cord of the Lewis rat during acute experimental allergic encephalomyelitis. J Immunol 131:2805-2809.
24. Husby S, Mestecky J, Moldoveanu Z, Holland S, Elson CO (1994): Oral tolerance in humans: T cell but not B cell tolerance after antigen feeding. J Immunol 152:4663-4670.
25. Hutchings PR, Cambridge G, Tile JP, Meager T, Cooke A (1989): The detection and enumeration of cytokine-secreting cells in mice and man and the clinical application of these assays. J Immunol Methods 120:1-8.
26. Javed NH, Gienapp IE, Cox KL, Whitacre CC (1995): Exquisite peptide specificity of oral tolerance in experimental autoimmune encephalomyelitis. J Immunol 155:1599-1605.
27. + Th1 but not Th2 cytokine responses. Int Immunol 6:721-730.
28. Karpus WJ, Lukacs NW (1996): The role of chemokines in oral tolerance: abrogation of nonresponsiveness by treatment with anti-monocyte chemotactic protein-1. Ann NY Acad Sci 778: 133-144.
29. Kaufman DL, Clare-Salzler M, Tian J, Forsthuber T, Ting GSP, Robinson P, Atkinson MA, Sercarz EE, Tobin AJ, Lehmann PV (1993): Spontaneous loss of T cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366:69-72.
30. Kay RA, Ferguson A (1989): The immunological consequences of feeding cholera toxin. II. Mechanisms responsible for the induction of oral tolerance for DTK. Immunology 66:416-421.
31. Kennedy MK, Tan LJ, Dal Canto MC, Tuohy VK, Lu ZJ, Trotter JL, Miller SD (1990): Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides. I Immunol 144:909-915.
32. Khare SD, Krco CJ, Griffiths MM, Luthra HS, David CS (1995): Oral administration of an immunodominant human collagen peptide modulates collagen-induced arthritis. I Immunol 155:3653-3659.
33. Khoury SJ, Hancock WW, Weiner HL (1992): Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor-β, interleukin 4, and prostaglandin E expression in the brain. J Exp Med 176:1355-1364.
34. Kuchroo VK, Sobel RA, Laning JC, Martin CA, Greenfield E, Dorf ME, Lees MB (1992): Experimental allergic encephalomyelitis mediated by cloned T cells specific for a synthetic peptide of myelin proteolipid protein: fine specificity and T cell receptor Vb usage. J Immunol 148:3776-3782.
35. Lees MB, Paxman SA (1974): Myelin proteins from different regions of the central nervous system. J Neurochem 23:825-831.
36. + T lymphocytes. J Immunol 142:748-752.
37. Liu GY, Wraith DC (1995): Affinity for class II MHC determines the extent to which soluble peptides tolerize autoreactive T cells in naive and primed adult mice-implications for autoimmunity. Int Immunol 7:1255-1263.
38. McRae BL, Kennedy MK, Tan LJ, Dal Canto MC, Miller SD (1992): Induction of active and adoptive chronic-relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein. I Neuroimmunol 38: 229-240.
39. McRae BL, Vanderlugt CL, Dal Canto MC, Miller SD (1995): Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J Exp Med 182:75-85.
40. Metzler B, Wraith DC (1993): Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int Immunol 5:1159-1165.
41. Michalek SM, Kiyono H, Wannemuehler MJ, MostellerLM, McGhee JR (1982): Lipopolysaccharide (LPS) regulation of the immune response: LPS influence on oral tolerance induction. J Immunol 128:1992-1998.
42. Michalek SM, McGhee JR, Kiyono H, Colwell DE, Eldridge JH, Wannemuehler MJ, Koopman WJ (1983): The IgA response: inductive aspects, regulatory cells, and effector functions. Ann N Y Acad Sci 409:48-71.
43. Miller SD, Hanson DG (1979): Inhibition of specific immune responses by feeding protein antigens. IV. Evidence for tolerance and specific active suppression of cell-mediated immune responses to ovalbumin. J Immunol 123:2344-2350.
44. Miller A, Lider O, Roberts AB, Sporn MB, Weiner HL (1992a): Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor β after antigen-specific triggering. Proc Natl Acad Sci USA 89:421-425.
45. Miller SD, Tan LJ, Pope L, McRae BL, Karpus WJ (1992b): Antigen-specific tolerance as a therapy for experimental autoimmune encephalomyelitis. Int Rev Immunol 9:203-232.
46. Miller A, Al-Sabbagh A, Santos LMB, Das MP, Weiner HL (1993): Epitopes of myelin basic protein that trigger TGF-β release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression. J Immunol 151:7307-7315.
47. Miller SD, McRae BL, Vanderlugt CL, Nikcevich KM, Pope JG, Pope L, Karpus WJ (1995): Evolution of the T-cell repertoire during the course of experimental immune-mediated demyelinating diseases. Immunol Rev 144:225-244.
48. Mu H-H, Sewell WA (1994): Regulation of DTH and IgE responses by IL-4 and IFN-γ in immunized mice given pertussis toxin. Immunology 83:639-645.
49. Nussenblatt RB, Caspi RR, Mahdi R, Chan C-C, Roberge F, Lider O, Weiner HL (1990): Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J Immunol 144:1689-1695.
50. Perry LL, Barzaga-Gilbert E, Trotter JL (1991): T cell sensitization to proteolipid protein in myelin basic protein-induced relapsing experimental allergic encephalomyelitis. J Neuroimmunol 33: 7-15.
51. Peterson JD, Karpus WJ, Clatch RJ, Miller SD (1993): Split tolerance of Th1 and Th2 cells in tolerance to Theiler's murine encephalomyelitis virus. Eur J Immunol 23:46-55.
52. Richman LK, Chiller JM, Brown WR, Hanson DG, Vaz NM (1978): Enterically induced immunologie tolerance. I. Induction of suppressor T lymphocytes by intragastric administration of soluble proteins. J Immunol 121:2429-2434.
53. Rizzo LV, Miller-Rivero NE, Chan C-C, Wiggert B, Nussenblatt RB, Caspi RR (1994): Interleukin-2 treatment potentiates induction of oral tolerance in a murine model of autoimmunity. J Clin Invest 94:1668-1672.
54. Russell G, Costales C (1980): Oral tolerance of Caloreen in babies, Arch Dis Child 55:886-887.
55. Satoh J, Koike F, Tabira T (1988): Experimental allergic encephalomyelitis mediated by murine encephalitogenic T-cell lines specific for myelin proteolipid apoprotein. Ann N Y Acad Sci 540:343-344.
56. Street NE, Mosmann TR (1991): Functional diversity of T lymphocytes due to secretion of different cytokine pattern. FASEB J 5:171-177.
57. Strobel S, Mowat AM, Drummond HE, Pickering MG, Ferguson A (1983): Immunological responses to fed protein antigens in mice: oral tolerance for CMI is due to activation of cyclophos- phamide-sensitive cells by gut-processed antigen. Immunology 49:451-456.
58. Sun J-B, Holmgren J, Czerkinsky C (1994): Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc Natl Acad Sci USA 91:10795-10799.
59. Takahashi I, Nakagawa I, Kiyono H, McGhee JR, Clements JD, Hamada S (1995): Mucosal T cells induce systemic anergy for oral tolerance. Biochem Biophys Res Commun 206:414-420.
60. Thurau SR, Chan CC, Suh E, Nussenblatt RB (1991): Induction of oral tolerance to S-antigen induced experimental autoimmune uveitis by a uveitogenic 20mer peptide. J Autoimmunity 4:507-516.
61. Trentham DE, Dynesius-Trentham RA, Orav EJ, Combitchi D, Lorenzo C, Sewell KL, Hafler DA, Weiner HL (1993): Effects of oral administration of type II collagen on rheumatoid arthritis. Science 261:1727-1730.
62. Tuohy VK, Lu ZJ, Sobel RA, Laursen RA, Lees MB (1988): A synthetic peptide from myelin proteolipid protein induces experimental allergic encephalomyelitis. J Immunol 141:1126-1130.
63. Tuohy VK, Sobel RA, Lu Z, Laursen RA, Lees MB (1992): Myelin proteolipid protein: minimum sequence requirements for active induction of autoimmune encephalomyelitis in SWR/J and SJL/J mice. J Neuroimmunol 39:67-74.
64. Tuohy VK, Thomas DM (1995): Sequence 104-117 of myelin proteolipid protein is a cryptic encephalitogenic T cell determinant for SJL/J mice. J Neuroimmunol 56:161-170.
65. Vandenbark AA, Celnik B, Vainiene M, Miller SD, Offner H (1995): Myelin antigen-coupled splenocytes suppress experimental autoimmune encephalomyelitis in Lewis rats through a partially reversible anergy mechanism. J Immunol 155:5861-5867.
66. Wang Z-Y, Huang J, Olsson T, He B, Link H (1995): B cell responses to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis. J Neurol Sci 128:167-174.
67. Weiner HL (1993): Treatment of autoimmune diseases by oral tolerance to autoantigens. Autoimmunity 15:6-7.
68. Weiner HL, Mackin GA, Matsui M, Orav EJ, Khoury SJ, Dawson DM, Hafler DA (1993): Double-blind pilot trial of oral tolerance with myelin antigens in multiple sclerosis. Science 259: 1321-1323.
69. Weiner HL (1994): Oral tolerance. Proc Natl Acad Sci USA 91: 10762-10765.
70. Wekerle H (1991): Immunopathogenesis of multiple sclerosis. Acta Neurol (Napoli) 13:197-204.
71. Whitacre CC, Gienapp IE, Orosz CG, Bitar DM (1991): Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J Immunol 147:2155-2163.
72. Whitham RH, Bourdette DN, Hashim GA, Herndon RM, Ilg RC, Vandenbark AA, Offner H (1991): Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis. J Immunol 146: 101-107.
73. Wildner G, Thurau SR (1995): Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye. Eur J Immunol 25:1292-1297.
74. Zhang ZY, Lee CS, Lider O, Weiner HL (1990): Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen. J Immunol 145:2489-2493.